Race Oncology Limited (RAONF)
USD 1.22
(0.0%)
USD 1.22
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -13.38 Million AUD | -3.03% |
| 2023 | -12.98 Million AUD | -9.13% |
| 2022 | -7.92 Million AUD | -63.01% |
| 2021 | -4.86 Million AUD | -78.31% |
| 2020 | -2.72 Million AUD | -3.26% |
| 2019 | -2.64 Million AUD | 43.53% |
| 2018 | -4.67 Million AUD | -50.82% |
| 2017 | -3.1 Million AUD | -739.18% |
| 2016 | -369.47 Thousand AUD | -429.17% |
| 2015 | -69.82 Thousand AUD | 22.24% |
| 2014 | -89.79 Thousand AUD | -647.55% |
| 2013 | -12.01 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -5.47 Million USD | 0.0% |
| 2024 Q2 | -6.54 Million USD | 0.0% |
| 2023 Q4 | -4.94 Million USD | 0.0% |
| 2023 FY | -8.64 Million AUD | -9.13% |
| 2023 Q2 | -3.79 Million USD | 0.0% |
| 2022 Q2 | -3.82 Million USD | 0.0% |
| 2022 FY | -7.92 Million AUD | -63.01% |
| 2022 Q4 | -4.28 Million USD | 0.0% |
| 2021 Q4 | -3.08 Million USD | 0.0% |
| 2021 FY | -4.86 Million AUD | -78.31% |
| 2021 Q2 | -1.82 Million USD | 0.0% |
| 2020 Q4 | -1.63 Million USD | 0.0% |
| 2020 Q2 | -1.11 Million USD | 0.0% |
| 2020 FY | -2.72 Million AUD | -3.26% |
| 2019 FY | -2.64 Million AUD | 43.53% |
| 2019 Q4 | -1.11 Million USD | 0.0% |
| 2018 FY | -4.67 Million AUD | -50.82% |
| 2017 FY | -3.1 Million AUD | -739.18% |
| 2016 FY | -369.47 Thousand AUD | -429.17% |
| 2015 FY | -69.82 Thousand AUD | 22.24% |
| 2014 FY | -89.79 Thousand AUD | -647.55% |
| 2013 FY | -12.01 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 81.36% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 372.25% |
| SQZ Biotechnologies Company | -75.82 Million USD | 82.353% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 25.026% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 116.347% |
| Mesoblast Limited | -84.14 Million USD | 84.099% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -771.102% |
| Genus plc | 6.4 Million USD | 309.071% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 237.343% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -1336.638% |
| Marizyme, Inc. | -34.08 Million USD | 60.745% |
| ContraFect Corporation | -56.88 Million USD | 76.48% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -60.246% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -193.773% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -854.397% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -369.41% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -386.417% |
| MultiCell Technologies, Inc. | -722.81 USD | -1851086.204% |
| Accustem Sciences Inc. | -3.74 Million USD | -257.156% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 77.317% |
| EV Biologics, Inc. | -483.06 Thousand USD | -2669.947% |
| Q BioMed Inc. | -3.44 Million USD | -288.336% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 477.982% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -3334.7% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -409.246% |
| Biomind Labs Inc. | -1 Million USD | -1225.329% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | -174.217% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -101.271% |
| Skye Bioscience, Inc. | -13.67 Million USD | 2.13% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -573.582% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -44573.341% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -165.251% |
| IMV Inc. | -38.67 Million USD | 65.399% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 15.685% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -592.357% |
| GB Sciences, Inc. | -1.42 Million USD | -841.955% |
| Alpha Cognition Inc. | -9.7 Million USD | -37.864% |
| HST Global, Inc. | -140.9 Thousand USD | -9396.021% |
| CSL Limited | 3.7 Billion USD | 100.361% |
| Halberd Corporation | -75.05 Thousand USD | -17728.859% |
| Enzolytics Inc. | -2.14 Million USD | -522.699% |
| Resverlogix Corp. | -12.74 Million USD | -4.954% |
| Affymax, Inc. | -15.04 Million USD | 11.069% |
| SYBLEU INC | -149.18 Thousand USD | -8869.405% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -322.33% |
| argenx SE | -425.04 Million USD | 96.852% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 75.894% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -1181.663% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -747.217% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -292.97% |
| AVAX Technologies, Inc. | 6.69 Million USD | 299.922% |
| Zenith Capital Corp. | -8.94 Million USD | -49.62% |
| Genscript Biotech Corporation | -415.79 Million USD | 96.782% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -76707.066% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -444.963% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -7701.641% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 75.659% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -361.2% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -1259.74% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -617.699% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -965.331% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -567.44% |
| BioStem Technologies, Inc. | -7.77 Million USD | -72.009% |
| ONE Bio Corp. | 13.68 Million USD | 197.8% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -7272.818% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -901.966% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -1089.482% |
| Agentix Corp. | -1.37 Million USD | -875.433% |
| LadRx Corporation | -3.82 Million USD | -249.944% |
| Cell Source, Inc. | -4.32 Million USD | -209.352% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -3120.514% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -1847.821% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -1847.821% |
| NovAccess Global Inc. | -2.46 Million USD | -442.435% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -358.326% |
| Itoco Inc. | -919.14 Thousand USD | -1355.769% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -215.697% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -1095.76% |
| Kadimastem Ltd | -3.04 Million USD | -340.114% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -5012.43% |
| CytoDyn Inc. | -18.05 Million USD | 25.902% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -53060.743% |
| Mobile Lads Corp. | -554.55 Thousand USD | -2312.868% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -5979.917% |
| Qrons Inc. | -643.67 Thousand USD | -1978.769% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -2269.402% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -500.058% |
| Rebus Holdings, Inc. | -664 Thousand USD | -1915.144% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -636.685% |
| International Stem Cell Corporation | -663 Thousand USD | -1918.184% |
| Bioxytran, Inc. | -3.82 Million USD | -250.263% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -25318.995% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -65684.459% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 63.104% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -726.981% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -1718.418% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -330.105% |
| Neutra Corp. | -229.48 Thousand USD | -5730.665% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 23.71% |
| PureTech Health plc | -146.19 Million USD | 90.848% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 37.739% |
| IXICO plc | -1.43 Million USD | -831.145% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -40.982% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 89.015% |
| CSL Limited | 3.81 Billion USD | 100.351% |
| Cellectis S.A. | -108.85 Million USD | 87.708% |